These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23410564)

  • 21. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.
    Hansel B; Potier L; Chalopin S; Larger E; Gautier JF; Delestre F; Masdoua V; Visseaux B; Lucet JC; Kerneis S; Abouleka Y; Thebaut JF; Riveline JP; Kadouch D; Roussel R
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2605-2611. PubMed ID: 34348875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
    Tanvig M
    Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials.
    Ge L; Sadeghirad B; Ball GDC; da Costa BR; Hitchcock CL; Svendrovski A; Kiflen R; Quadri K; Kwon HY; Karamouzian M; Adams-Webber T; Ahmed W; Damanhoury S; Zeraatkar D; Nikolakopoulou A; Tsuyuki RT; Tian J; Yang K; Guyatt GH; Johnston BC
    BMJ; 2020 Apr; 369():m696. PubMed ID: 32238384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis.
    Ho M; Garnett SP; Baur L; Burrows T; Stewart L; Neve M; Collins C
    Pediatrics; 2012 Dec; 130(6):e1647-71. PubMed ID: 23166346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults.
    Crowe C; Gibson I; Cunningham K; Kerins C; Costello C; Windle J; O Shea PM; Hynes M; McGuire B; Kilkelly K; Griffin H; O Brien T; Jones J; Finucane FM
    BMC Endocr Disord; 2015 Aug; 15():37. PubMed ID: 26231181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.
    Hobkirk JP; King RF; Gately P; Pemberton P; Smith A; Barth JH; Carroll S
    Metab Syndr Relat Disord; 2012 Feb; 10(1):20-5. PubMed ID: 21936669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?
    Reinehr T; Lass N; Toschke C; Rothermel J; Lanzinger S; Holl RW
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3171-9. PubMed ID: 27285295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Exercise Intervention for Weight Loss in Overweight and Obese Adolescents: Meta-Analysis and Implications.
    Stoner L; Rowlands D; Morrison A; Credeur D; Hamlin M; Gaffney K; Lambrick D; Matheson A
    Sports Med; 2016 Nov; 46(11):1737-1751. PubMed ID: 27139723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
    ; Wing RR; Bolin P; Brancati FL; Bray GA; Clark JM; Coday M; Crow RS; Curtis JM; Egan CM; Espeland MA; Evans M; Foreyt JP; Ghazarian S; Gregg EW; Harrison B; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Reboussin D; Regensteiner JG; Rickman AD; Ryan DH; Safford M; Wadden TA; Wagenknecht LE; West DS; Williamson DF; Yanovski SZ
    N Engl J Med; 2013 Jul; 369(2):145-54. PubMed ID: 23796131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin, adiponectin, and short-term and long-term weight loss after a lifestyle intervention in obese children.
    Siegrist M; Rank M; Wolfarth B; Langhof H; Haller B; Koenig W; Halle M
    Nutrition; 2013 Jun; 29(6):851-7. PubMed ID: 23422541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence.
    Reinehr T; Kleber M; Toschke AM
    Atherosclerosis; 2009 Nov; 207(1):174-80. PubMed ID: 19442975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study.
    Jakicic JM; Jaramillo SA; Balasubramanyam A; Bancroft B; Curtis JM; Mathews A; Pereira M; Regensteiner JG; Ribisl PM;
    Int J Obes (Lond); 2009 Mar; 33(3):305-16. PubMed ID: 19153582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body Weight Reduction of 5% Improved Blood Pressure and Lipid Profiles in Obese Men and Blood Glucose in Obese Women: A Four-Year Follow-up Observational Study.
    Hasegawa Y; Nakagami T; Oya J; Takahashi K; Isago C; Kurita M; Tanaka Y; Ito A; Kasahara T; Uchigata Y
    Metab Syndr Relat Disord; 2019 Jun; 17(5):250-258. PubMed ID: 30839239
    [No Abstract]   [Full Text] [Related]  

  • 35. Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.
    Espeland MA; Probstfield J; Hire D; Redmon JB; Evans GW; Coday M; Lewis CE; Johnson KC; Wilmoth S; Bahnson J; Dulin MF; Green JB; Knowler WC; Kitabchi A; Murillo AL; Osei K; Rehman SU; Cushman WC; ;
    Am J Hypertens; 2015 Aug; 28(8):995-1009. PubMed ID: 25666468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
    Ikramuddin S; Korner J; Lee WJ; Connett JE; Inabnet WB; Billington CJ; Thomas AJ; Leslie DB; Chong K; Jeffery RW; Ahmed L; Vella A; Chuang LM; Bessler M; Sarr MG; Swain JM; Laqua P; Jensen MD; Bantle JP
    JAMA; 2013 Jun; 309(21):2240-9. PubMed ID: 23736733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
    Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
    Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease.
    Lavie CJ; Milani RV
    Chest; 1996 Jan; 109(1):52-6. PubMed ID: 8549217
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.